DNM1L and glioblastoma: To highlight the relevance of this modification in a disease state, we used the same method to isolate O-GlcNAcylated Drp1 in four GBM cell lines (rat, CNS1, and human, Gli36, LN229, and U87) and compared the abundance of modified protein with amounts in healthy astrocytes (Fig. 4B).